Opioid receptor upregulation in μ-opioid receptor deficient CXBK and outbred Swiss Webster mice
- 4 June 1999
- journal article
- Published by Elsevier in Life Sciences
- Vol. 65 (2) , 113-123
- https://doi.org/10.1016/s0024-3205(99)00228-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Effect of μ-Opioid Receptor Antisense on Morphine Potency and Antagonist-Induced Supersensitivity and Receptor UpregulationBrain Research Bulletin, 1997
- Chronic morphine and naltrexone fail to modify μ-opioid receptor mRNA levels in the rat brainMolecular Brain Research, 1997
- The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNAEuropean Journal of Pharmacology, 1995
- Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levelsMolecular Brain Research, 1995
- Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatmentBrain Research, 1995
- Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivityPharmacology Biochemistry and Behavior, 1995
- Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male miceRegulatory Peptides, 1994
- Chronic opioid antagonist treatment: assessment of receptor upregulationEuropean Journal of Pharmacology, 1989
- Differential up-regulation of microsomal and synaptic membrane μ opioid receptorsBiochemical and Biophysical Research Communications, 1985
- Naltrexone-induced opiate receptor supersensitivityBrain Research, 1982